Abelcet Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Alerts
• Clinical Trials

VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults
Conditions:   Invasive Aspergillosis;   Invasive Pulmonary Aspergillosis Interventions:   Drug: Investigational Agent: VL-2397;   Drug: Standard treatment: Voriconazole, Isavuconazole, or Liposomal amphotericin B Sponsor:   Vical Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2017 Category: Research Source Type: clinical trials